However, similar to studies in colonic epithelial cells [27], we found that JAM-A knockdown or inhibition in breast cancer cells significantly reduced the activity of Rap1 GTPase, a known activator of β1-integrins [24] and a regulator of cellular adhesion [51]. This evidence concerns the gene F11R and breast cancer.